Clinical Trials for Mycosis Fungoides

Find clinical trials for mycosis fungoides. Discover research opportunities and treatment options in your area.

25 Active Trials Found

Showing 25 trials on this page

Page 1 of 2

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

NCT ID: NCT06470451

This clinical trial is studying a treatment called HyBryte, which is a special cream used to help patients with a type of skin cancer known as cutaneous T-cell lymphoma (CTCL), specifically during ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Philadelphia, Pennsylvania, United States +15 more

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

NCT ID: NCT05357794

This clinical trial is studying whether a new combination treatment can effectively manage mycosis fungoides, a type of skin lymphoma. The treatment includes a special form of radiation called ultr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)

NCT ID: NCT06235281

The PLIGHT trial is studying a combination of two treatments—phototherapy and a medication called mogamulizumab (POTELIGEO)—for patients with early-stage mycosis fungoides, a type of skin lymphoma....

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Tampa, Florida, United States

A Registry for People With T-cell Lymphoma

NCT ID: NCT05978141

This clinical trial is a registry study aimed at gathering information about various types of T-cell lymphoma, which is a group of cancers that affect a type of white blood cell called T-cells. By ...

Recruiting

Type: observational Locations: New York, New York, United States, Harrison, New York, United States +24 more

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

NCT ID: NCT03398161

This clinical trial is looking at how effective ultra low dose radiation therapy is for treating patients with mycosis fungoides, a type of skin cancer. Radiation therapy uses high-energy X-rays to...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

NCT ID: NCT03587844

This clinical trial is studying the effects of a medication called brentuximab vedotin, specifically at a lower dose than what is currently approved by the FDA. The trial aims to find out how well ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Stanford, California, United States, New York, New York, United States +6 more

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

NCT ID: NCT04234048

This clinical trial is investigating a new treatment called ST-001, which is a special formulation of a drug known as fenretinide. The trial focuses on patients with various types of T-cell non-Hod...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Ann Arbor, Michigan, United States +9 more

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

NCT ID: NCT03602157

This clinical trial is studying a new type of treatment for certain types of lymphoma, which is a cancer of the immune system. The treatment involves using specially modified T cells (a type of whi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

NCT ID: NCT04960618

This clinical trial is investigating whether combining two medications, pembrolizumab and gemcitabine, is an effective treatment for advanced mycosis fungoides and Sézary syndrome, which are types ...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +6 more

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

NCT ID: NCT04904146

This clinical trial is focused on understanding two specific skin conditions: Mycosis Fungoides (MF) and Sézary Syndrome (SS). Researchers are trying to find out more about certain markers in the b...

Recruiting

Type: observational Locations: Lund, , Sweden

Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and Sézary Syndrome

NCT ID: NCT05944562

This clinical trial is studying a medication called CPI-0209 to see if it is safe and effective for patients with advanced mycosis fungoides or Sézary syndrome, which are types of skin lymphoma. Th...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

NCT ID: NCT06207812

This clinical trial is looking into the long-term effects of two skin conditions called juvenile-onset mycosis fungoides and lymphomatoid papulosis in young patients. The goal is to follow up with ...

Recruiting

Type: observational Locations: Houston, Texas, United States, Houston, Texas, United States

Treatment of Mycosis Fungoides with Hypericin Ointment and Visible Light

NCT ID: NCT05872854

This clinical trial is investigating a new treatment for a type of skin cancer called mycosis fungoides, which is a form of cutaneous T-cell lymphoma. The treatment involves using a special ointmen...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

NCT ID: NCT00177268

This clinical trial is focused on collecting blood, urine, and tissue samples from patients diagnosed with certain skin conditions, specifically cutaneous T-cell lymphoma (CTCL), eczema, and atopic...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/refractory Indolent T/NK-cell Lymphomas

NCT ID: NCT06716658

This clinical trial is studying a new treatment called Golidocitnib for patients with indolent T/NK-cell lymphomas, which are types of blood cancers that grow slowly but are currently hard to cure....

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, , China, Tianjin, Tianjin, China

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

NCT ID: NCT06508463

This clinical trial is investigating a new treatment approach for patients with certain types of T-cell lymphoma, such as peripheral T-cell lymphoma and anaplastic large cell lymphoma. The treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Rochester, Minnesota, United States

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

NCT ID: NCT02848274

This clinical trial is focused on understanding mycosis fungoides and Sezary syndrome, which are rare types of skin and blood cancers. The main goal is to create a tool that helps doctors predict h...

Recruiting

Type: observational Locations: Iowa City, Iowa, United States, Hackensack, New Jersey, United States +11 more

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

NCT ID: NCT05414500

This clinical trial is studying the safety and effectiveness of two medications, Mogamulizumab and Brentuximab Vedotin, for treating specific types of skin lymphomas called Cutaneous T Cell Lymphom...

Recruiting

Phase: PHASE1 Type: interventional Locations: Birmingham, Alabama, United States

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

NCT ID: NCT04256018

This clinical trial is studying a new treatment approach for patients with two types of skin lymphomas called Mycosis Fungoides (MF) and Sézary Syndrome (SS). The researchers want to find out if co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Stanford, California, United States

BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma

NCT ID: NCT05538988

This clinical trial is studying a treatment called cemiplimab for patients with advanced cutaneous T-cell lymphoma, specifically a type known as mycosis fungoides (MF). MF is a rare skin cancer tha...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Edmonton, Alberta, Canada, Edmonton, Alberta, Canada

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions